MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group.
Nat Rev Neurol. 2020 Mar;16(3):171-182.
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease
von Essen MR, Hellem MNN, Vinther-Jensen T, Ammitzbøll C, Hansen RH, Hjermind LE, Nielsen TT, Nielsen JE, Sellebjerg F.
Ann Neurol. 2020 Feb;87(2):246-255.
Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintoré M.
Brain. 2020 Sep 1;143(9):2637-2652.
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium.
Science. 2019 Sep 27;365(6460):7188.
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
von Essen MR, Ammitzbøll C, Hansen RH, Petersen ERS, McWilliam O, Marquart HV, Damm P, Sellebjerg F.
Brain. 2019 Jan 1;142(1):120-132.
GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis
Ammitzbøll C, von Essen MR, Börnsen L, Petersen ER, McWilliam O, Ratzer R, Romme Christensen J, Oturai AB, Søndergaard HB, Sellebjerg F.
J Autoimmun. 2019 Feb;97:114-121.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, et al.
JAMA Neurol. 2019 Jun 17;76(9):1035-48.
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, et al.
Lancet Neurol. 2018 Feb;17(2):162-173.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators.
Lancet Neurol. 2018 May;17(5):405-415.
Evolving concepts in the treatment of relapsing multiple sclerosis
Comi G, Radaelli M, Soelberg Sørensen P.
Lancet. 2017 Apr 1;389(10076):1347-1356.
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Gr. Ann Neurol. 2017 Jul;82(1):20-29.
Ozanimod: a better or just another S1P receptor modulator?
Sørensen PS.
Lancet Neurol. 2016 Apr;15(4):345-7.
Multiple sclerosis. Generic glatiramer acetate - a step toward cheaper MS drugs?
Sørensen PS.
Nat Rev Neurol. 2016 Jan;12(1):5-6.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I; IMSVISUAL consortium.
Lancet Neurol. 2016 May;15(6):574-84.
Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators.
Lancet. 2016 Mar 12;387(10023):1075-1084.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Sellebjerg F, Oturai AB.
Nat Rev Neurol. 2015 Jul;11(7):371-2.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF.
Ann Neurol. 2015 Nov;78(5):710-21.
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders
Taylor JC, Martin HC, Lise S, Broxholme J, Cazier JB, Rimmer A, Kanapin A, Lunter G, Fiddy S, Allan C, Aricescu AR, Attar M, Babbs C, Becq J, Beeson D, Bento C, Bignell P, Blair E, Buckle VJ, Bull K, Cais O, Cario H, Chapel H, Copley RR, Cornall R, Craft J, Dahan K, Davenport EE, Dendrou C, et al.
Nat Genet. 2015 Jul;47(7):717-726.
Class II HLA interactions modulate genetic risk for multiple sclerosis
Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A, et al.
Nat Genet. 2015 Oct;47(10):1107-1113.
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, et al.
Brain. 2015 Mar;138(Pt 3):632-43.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
Liu Y, Carlsson R, Comabella M, Wang J, Kosicki M, Carrion B, Hasan M, Wu X, Montalban X, Dziegiel MH, Sellebjerg F, Sørensen PS, Helin K, Issazadeh-Navikas S.
Nat Med. 2014 Mar;20(3):272-82.
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls
International Multiple Sclerosis Genetics Consortium.
Am J Hum Genet. 2013 Jun 6;92(6):854-65.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, McCauley JL.
Nat Genet. 2013 Nov;45(11):1353-60.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Compston A.
Nature. 2011 Aug 10;476(7359):214-9.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB; SIMCOMBIN study investigators.
Lancet Neurol. 2011 Aug;10(8):691-701.
Demyelination versus remyelination in progressive multiple sclerosis
Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H.
Brain. 2010 Oct;133(10):2983-98.
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen N, Sørensen PS.
Lancet Neurol. 2010 May;9(5):520-32
Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA, et al.
Am J Hum Genet. 2010 Feb 12;86(2):285-91
2020 |
MAIT cell subtypes in multiple sclerosis. Ammitzbøll C, von Essen MR, Chow HH, McWilliam O, Holm Hansen R, Sellebjerg F. J Neuroimmunol. 2020 Feb 15;339:577117. |
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, Kuhle J, Ascherio A; BENEFIT Study Group. Neurology. 2020 May 5;94(18):e1950-e1960. |
Holm Hansen R, Højsgaard Chow H, Christensen JR, Sellebjerg F, von Essen MR. Mult Scler Relat Disord. 2020 Jan;37:101451. |
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis. Sellebjerg F, Blinkenberg M, Sorensen PS. CNS Drugs. 2020 Mar;34(3):269-280. |
Serum neurofilament light as a biomarker in progressive multiple sclerosis. Kapoor R, Smith KE, Allegretta M, Arnold DL, Carroll W, Comabella M, Furlan R, Harp C, Kuhle J, Leppert D, Plavina T, Sellebjerg F, Sincock C, Teunissen CE, Topalli I, von Raison F, Walker E, Fox RJ. Neurology. 2020 Sep 8;95(10):436-444. |
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease. von Essen MR, Hellem MNN, Vinther-Jensen T, Ammitzbøll C, Hansen RH, Hjermind LE, Nielsen TT, Nielsen JE, Sellebjerg F. Ann Neurol. 2020 Feb;87(2):246-255. |
Aggressive multiple sclerosis (1): Towards a definition of the phenotype. Iacobaeus E, Arrambide G, Amato MP, Derfuss T, Vukusic S, Hemmer B, Tintore M, Brundin L; 2018 ECTRIMS Focused Workshop Group. Mult Scler. 2020 Jun 12;26(9):1352458520925369. |
Aggressive multiple sclerosis (2): Treatment. Arrambide G, Iacobaeus E, Amato MP, Derfuss T, Vukusic S, Hemmer B, Brundin L, Tintore M; 2018 ECTRIMS Focused Workshop Group. Mult Scler. 2020 Jun 12;26(9):1352458520924595. |
Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintoré M. Brain. 2020 Sep 1;143(9):2637-2652. |
Marstrand L, Østerberg O, Walsted T, Skov AC, Schreiber KI, Sellebjerg F. Mult Scler Relat Disord. 2020 Jan;37:101458. |
Krogh Nielsen M, Subhi Y, Rue Molbech C, Sellebjerg F, Sørensen TL. Acta Ophthalmol. 2020 May;98(3):e393-e394. |
Papp V, Petersen T, Magyari M, Koch-Henriksen N, Frederiksen JL, Sellebjerg F, Stenager E, Illes Z. Neurology. 2020 Jun 9;94(23):1048-1049. |
Biomarkers of inflammation and epithelial barrier function in multiple sclerosis. Olsson A, Gustavsen S, Hasselbalch IC, Langkilde AR, Sellebjerg F, Oturai AB, Søndergaard HB. Mult Scler Relat Disord. 2020 Sep 19;46:102520. |
Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis. Mahler MR, Søndergaard HB, Buhelt S, von Essen MR, Romme Christensen J, Enevold C, Sellebjerg F. Mult Scler Relat Disord. 2020 Oct;45:102391. |
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study. Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M. Neurology. 2020 Aug 25;95(8):e1041-e1051. |
Oturai DB, Bach Søndergaard H, Koch-Henriksen N, Andersen C, Laursen JH, Gustavsen S, Kristensen JT, Magyari M, Sørensen PS, Sellebjerg F, Thørner LW, Ullum H, Oturai AB. Mult Scler. 2020 Mar 23:1352458520912500. |
Andersen KW, Lasič S, Lundell H, Nilsson M, Topgaard D, Sellebjerg F, Szczepankiewicz F, Siebner HR, Blinkenberg M, Dyrby TB. Brain Commun. 2020 Jun 8;2(2):fcaa077. |
Andlauer TFM, Link J, Martin D, Ryner M, Hermanrud C, Grummel V, Auer M, Hegen H, Aly L, Gasperi C, Knier B, Müller-Myhsok B, Jensen PEH, Sellebjerg F, Kockum I, Olsson T, Pallardy M, Spindeldreher S, Deisenhammer F, Fogdell-Hahn A, Hemmer B; ABIRISK consortium. BMC Med. 2020 Nov 4;18(1):298. |
Bauer C, Dyrby TB, Sellebjerg F, Madsen KS, Svolgaard O, Blinkenberg M, Siebner HR, Andersen KW. Neuroimage Clin. 2020 Aug 25;28:102393. |
Marstrand L, Østerberg O, Walsted T, Skov AC, Schreiber KI, Sellebjerg F. Mult Scler Relat Disord. 2020 Feb;38:101942. |
Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group. Nat Rev Neurol. 2020 Mar;16(3):171-182. |
de Sitter A, Visser M, Brouwer I, Cover KS, van Schijndel RA, Eijgelaar RS, Müller DMJ, Ropele S, Kappos L, Rovira Á, Filippi M, Enzinger C, Frederiksen J, Ciccarelli O, Guttmann CRG, Wattjes MP, Witte MG, de Witt Hamer PC, Barkhof F, Vrenken H; MAGNIMS Study Group and Alzheimer’s Disease Neuroimaging Initiative. Eur Radiol. 2020 Feb;30(2):1062-1074. |
Comorbidity in Multiple Sclerosis. Magyari M, Sorensen PS. Front Neurol. 2020 Aug 21;11:851. |
Ibfelt EH, Jacobsen RK, Kopp TI, Cordtz RL, Jakobsen AS, Seersholm N, Shaker SB, Dreyer L. Rheumatology (Oxford). 2020 Aug 11:327. |
COVID-19 in people with multiple sclerosis: A global data sharing initiative. Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A, Kalincik T, Edan G, Simpson-Yap S, De Raedt L, Dauxais Y, Gautrais C, Rodrigues PR, McKenna L, Lazovski N, Hillert J, Forsberg L, Spelman T, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo BF, Rojas JI, van der Walt A, Butzkueven H, van der Mei I, Ivanov R, Hellwig K, Sciascia do Olival G, Cohen JA, Van Hecke W, Dobson R, Magyari M, Brum DG, Alonso R, Nicholas R, Bauer J, Chertcoff A, de Sèze J, Louapre C, Comi G, Rijke N. Mult Scler. 2020 Sep;26(10):1157-1162. |
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study. Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M. Neurology. 2020 Aug 25;95(8):e1041-e1051. |
Dalla Costa G, Leocani L, Montalban X, Guerrero AI, Sørensen PS, Magyari M, Dobson RJB, Cummins N, Narayan VA, Hotopf M, Comi G; RADAR-CNS consortium. Neurol Sci. 2020 Jul;41(7):1647-1650. |
Pharmacotherapeutic considerations in women with multiple sclerosis. Andersen JB, Magyari M. Expert Opin Pharmacother. 2020 Sep;21(13):1591-1602 |
Papp V, Petersen T, Magyari M, Koch-Henriksen N, Frederiksen JL, Sellebjerg F, Stenager E, Illes Z. Neurology. 2020 Jun 9;94(23):1048-1049. |
Oturai DB, Bach Søndergaard H, Koch-Henriksen N, Andersen C, Laursen JH, Gustavsen S, Kristensen JT, Magyari M, Sørensen PS, Sellebjerg F, Thørner LW, Ullum H, Oturai AB. Mult Scler. 2020 Mar 23:1352458520912500. |
Kopp TI, Vogel U, Andersen V. PLoS One. 2020 Feb 3;15(2):e0228635. |
Kopp TI, Blinkenberg M, Petersen T, Sorensen PS, Magyari M. Mult Scler Relat Disord. 2020 May;40:101956. |
Boesen MS, Blinkenberg M, Thygesen LC, Eriksson F, Magyari M. Mult Scler. 2020 Sep 25:1352458520959673. |
Rubin KH, Rasmussen NF, Petersen I, Kopp TI, Stenager E, Magyari M, Hetland ML, Bygum A, Glintborg B, Andersen V. Int J Med Sci. 2020 Sep 9;17(16):2487-2495. |
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study. Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C. Mult Scler. 2020 Jul;26(8):912-923. |
Passali M, Josefsen K, Frederiksen JL, Antvorskov JC. Nutrients. 2020 Aug 1;12(8):2316. |
Functional-structural assessment of the optic pathways in patients with optic neuritis. Schmidt MF, Pihl-Jensen G, Frederiksen JL. Doc Ophthalmol. 2020 Apr;140(2):159-168. |
Sensitive Assessment of Acute Optic Neuritis by a New, Digital Flicker Test. Pihl-Jensen G, Ivanov I, Hinze D, Trauzettel-Klosinski S, Frederiksen JL. Ophthalmic Res. 2020;63(3):332-340. |
Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis. Mailand MT, Frederiksen JL. Mol Diagn Ther. 2020 Jun;24(3):263-277. |
Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis. Ahmad U, Frederiksen JL. Mult Scler Relat Disord. 2020 Sep 18;46:102509. |
Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis. Houen G, Heiden J, Trier NH, Draborg AH, Benros ME, Zinkevičiūtė R, Petraitytė-Burneikienė R, Ciplys E, Slibinskas R, Frederiksen JL. J Neuroimmunol. 2020 Jul 7;346:577314. |
Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13. Olesen MN, Nilsson AC, Pihl-Jensen G, Soelberg KK, Olsen DA, Brandslund I, Lillevang ST, Madsen JS, Frederiksen JL, Asgari N. Mult Scler Relat Disord. 2020 Jun 11;44:102281. |
Pihl-Jensen G, Wanscher B, Frederiksen JL. Mult Scler. 2020 Jun 8:1352458520917924. |
de Sitter A, Verhoeven T, Burggraaff J, Liu Y, Simoes J, Ruggieri S, Palotai M, Brouwer I, Versteeg A, Wottschel V, Ropele S, Rocca MA, Gasperini C, Gallo A, Yiannakas MC, Rovira A, Enzinger C, Filippi M, De Stefano N, Kappos L, Frederiksen JL, Uitdehaag BMJ, Barkhof F, Guttmann CRG, Vrenken H; MAGNIMS Study Group. J Neurol. 2020 Dec;267(12):3541-3554. |
A novel neurodegenerative spectrum disorder in patients with MLKL deficiency. Faergeman SL, Evans H, Attfield KE, Desel C, Kuttikkatte SB, Sommerlund M, Jensen LT, Frokiaer J, Friese MA, Matthews PM, Luchtenborg C, Brügger B, Oturai AB, Dendrou CA, Fugger L. Cell Death Dis. 2020 May 1;11(5):303. |
Hässler S, Bachelet D, Duhaze J, Szely N, Gleizes A, Hacein-Bey Abina S, Aktas O, Auer M, Avouac J, Birchler M, Bouhnik Y, Brocq O, Buck-Martin D, Cadiot G, Carbonnel F, Chowers Y, Comabella M, Derfuss T, De Vries N, Donnellan N, Doukani A, Guger M, Hartung HP, Kubala Havrdova E, Hemmer B, Huizinga T, Ingenhoven K, Hyldgaard-Jensen PE, Jury EC, Khalil M, Kieseier B, Laurén A, Lindberg R, Loercher A, Maggi E, Manson J, Mauri C, Mohand Oumoussa B, Montalban X, Nachury M, Nytrova P, Richez C, Ryner M, Sellebjerg F, Sievers C, Sikkema D, Soubrier M, Tourdot S, Trang C, Vultaggio A, Warnke C, Spindeldreher S, Dönnes P, Hickling TP, Hincelin Mery A, Allez M, Deisenhammer F, Fogdell-Hahn A, Mariette X, Pallardy M, Broët P; ABIRISK consortium. PLoS Med. 2020 Oct 30;17(10):e1003348. |
Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study. Jonsson DI, Sveinsson O, Hakim R, Brundin L. Neurology. 2019 Jul 9;93(2):e181-e189. |
Neurovascular contact plays no role in trigeminal neuralgia secondary to multiple sclerosis. Noory N, Smilkov EA, Frederiksen JL, Heinskou TB, Andersen ASS, Bendtsen L, Maarbjerg S. Cephalalgia. 2020 Nov 28:333102420974356. |
2019 |
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. International Multiple Sclerosis Genetics Consortium. Science. 2019 Sep 27;365(6460):7188. |
Holm Hansen R, Højsgaard Chow H, Sellebjerg F, Rode von Essen M. Mult Scler. 2019 Aug;25(9):1289-1297. |
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis. von Essen MR, Ammitzbøll C, Hansen RH, Petersen ERS, McWilliam O, Marquart HV, Damm P, Sellebjerg F. Brain. 2019 Jan 1;142(1):120-132. |
Pulsed immune reconstitution therapy in multiple sclerosis. Sorensen PS, Sellebjerg F. Ther Adv Neurol Disord. 2019 Mar 28;12:1756286419836913. |
The Multiple Sclerosis Care Unit. Soelberg Sorensen P, Giovannoni G, Montalban X, Thalheim C, Zaratin P, Comi G. Mult Scler. 2019 Apr;25(5):627-636. |
von Essen MR, Søndergaard HB, Petersen ERS, Sellebjerg F. Cells. 2019 Mar 26;8(3):285. |
Sellebjerg F, Royen L, Soelberg Sørensen P, Oturai AB, Jensen PEH. Mult Scler. 2019 Oct;25(11):1444-1451. |
Petersen ER, Søndergaard HB, Laursen JH, Olsson AG, Börnsen L, Soelberg Sørensen P, Sellebjerg F, Bang Oturai A. Mult Scler. 2019 Aug;25(9):1298-1305. |
Multiple sclerosis and cancer incidence: A Danish nationwide cohort study. Nørgaard M, Veres K, Didden EM, Wormser D, Magyari M. Mult Scler Relat Disord. 2019 Feb;28:81-85. |
Holm Hansen R, Højsgaard Chow H, Sellebjerg F, Rode von Essen M. Mult Scler. 2019 Aug;25(9):1289-1297. |
Multiple sclerosis registries in Europe - An updated mapping survey. Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C. Mult Scler Relat Disord. 2019 Jan;27:171-178. |
GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis. Ammitzbøll C, von Essen MR, Börnsen L, Petersen ER, McWilliam O, Ratzer R, Romme Christensen J, Oturai AB, Søndergaard HB, Sellebjerg F. J Autoimmun. 2019 Feb;97:114-121. |
Prediction of natalizumab anti-drug antibodies persistency. Deisenhammer F, Jank M, Lauren A, Sjödin A, Ryner M, Fogdell-Hahn A, Sievers C, Lindberg R, Jensen PE, Sellebjerg F, Christodoulou L, Birchler M, Pallardy M, Auer M, Liblau R; ABIRISK consortium. Mult Scler. 2019 Mar;25(3):392-398. |
Romme Christensen J, Komori M, von Essen MR, Ratzer R, Börnsen L, Bielekova B, Sellebjerg F. Mult Scler. 2019 Jun;25(7):937-946. |
Chalmer TA, Kalincik T, Laursen B, Sorensen PS, Magyari M; Members of Danish Multiple Sclerosis Group. J Neurol. 2019 Feb;266(2):306-315. |
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study. Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M. Neurology. 2019 Apr 16;92(16):e1811-e1820. |
Boesen MS, Koch-Henriksen N, Thygesen LC, Eriksson F, Greisen G, Born AP, Blinkenberg M, Uldall PV, Magyari M. Mult Scler. 2019 May;25(6):783-791. |
Arngrim N, Hougaard A, Schytz HW, Vestergaard MB, Britze J, Amin FM, Olsen KS, Larsson HB, Olesen J, Ashina M. J Cereb Blood Flow Metab. 2019 Apr;39(4):680-689. |
Andersen C, Søndergaard HB, Bang Oturai D, Laursen JH, Gustavsen S, Larsen NK, Magyari M, Just-Østergaard E, Thørner LW, Sellebjerg F, Ullum H, Oturai AB. Mult Scler. 2019 Oct;25(12):1572-1579. |
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ. JAMA Neurol. 2019 Jun 17;76(9):1035-48. |
2018 |
Progressive multiple sclerosis, cognitive function, and quality of life. Højsgaard Chow H, Schreiber K, Magyari M, Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Soelberg Sørensen P, Sellebjerg F. Brain Behav. 2018 Jan 5;8(2):e00875. |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Lancet Neurol. 2018 Feb;17(2):162-173. |
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study. Bar-Or A, Grove RA, Austin DJ, Tolson JM, VanMeter SA, Lewis EW, Derosier FJ, Lopez MC, Kavanagh ST, Miller AE, Sorensen PS. Neurology. 2018 May 15;90(20):e1805-e1814. |
Optical coherence tomography in multiple sclerosis. Britze J, Frederiksen JL. Eye (Lond). 2018 May;32(5):884-888. |
Early versus later treatment start in multiple sclerosis: a register-based cohort study. Chalmer TA, Baggesen LM, Nørgaard M, Koch-Henriksen N, Magyari M, Sorensen PS; Danish Multiple Sclerosis Group. Eur J Neurol. 2018 Oct;25(10):1262-e110. |
Comi G, Cook S, Rammohan K, Soelberg Sorensen P, Vermersch P, Adeniji AK, Dangond F, Giovannoni G. Ther Adv Neurol Disord. 2018 Jan 23;11:1756285617753365. |
McWilliam O, Sellebjerg F, Marquart HV, von Essen MR. J Neuroimmunol. 2018 Nov 15;324:157-164. |
The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. Hasselbalch IC, Søndergaard HB, Koch-Henriksen N, Olsson A, Ullum H, Sellebjerg F, Oturai AB. Mult Scler J Exp Transl Clin. 2018 Nov 28;4(4):2055217318813183. |
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium. Cell. 2018 Nov 29;175(6):1679-1687.e7. |
Martin NA, Nawrocki A, Molnar V, Elkjaer ML, Thygesen EK, Palkovits M, Acs P, Sejbaek T, Nielsen HH, Hegedus Z, Sellebjerg F, Molnar T, Barbosa EGV, Alcaraz N, Gallyas F Jr, Svenningsen AF, Baumbach J, Lassmann H, Larsen MR, Illes Z. PLoS One. 2018 Aug 16;13(8):e0202530. |
Boesen MS, Thygesen LC, Uldall PV, Eriksson F, Born AP, Blinkenberg M, Koch-Henriksen N, Greisen G, Magyari M. Mult Scler Relat Disord. 2018 Jan;19:30-34. |
Boesen MS, Magyari M, Koch-Henriksen N, Thygesen LC, Born AP, Uldall PV, Blinkenberg M. Mult Scler. 2018 Jul;24(8):1077-1086. |
Male factor infertility and risk of multiple sclerosis: A register-based cohort study. Glazer CH, Tøttenborg SS, Giwercman A, Bräuner EV, Eisenberg ML, Vassard D, Magyari M, Pinborg A, Schmidt L, Bonde JP. Mult Scler. 2018 Dec;24(14):1835-1842. |
Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X, Soelberg Sørensen P, Miller DH; 2016 ECTRIMS Focused Workshop Group. Mult Scler. 2018 Apr 1;24(5):590-603. |
Disability in progressive MS is associated with T2 lesion changes. Ammitzbøll C, Dyrby TB, Lyksborg M, Schreiber K, Ratzer R, Romme Christensen J, Iversen P, Magyari M, Garde E, Sørensen PS, Siebner HR, Sellebjerg F. Mult Scler Relat Disord. 2018 Feb;20:73-77. |
Andersen JB, Moberg JY, Spelman T, Magyari M. Front Immunol. 2018 Nov 23;9:2706. |
Bihrmann K, Nielsen NM, Magyari M, Koch-Henriksen N, Nordsborg RB, Ersbøll AK. Mult Scler Relat Disord. 2018 Jul;23:40-45. |
Boesen MS, Blinkenberg M, Koch-Henriksen N, Thygesen LC, Uldall PV, Magyari M, Born AP. Dev Med Child Neurol. 2018 Nov;60(11):1123-1131. |
Boesen MS, Magyari M, Born AP, Thygesen LC. Clin Epidemiol. 2018 Apr 10;10:391-399. |
Boesen MS, Jensen PEH, Magyari M, Born AP, Uldall PV, Blinkenberg M, Sellebjerg F. Mult Scler Relat Disord. 2018 Aug;24:175-183. |
Fernández O, Delvecchio M, Edan G, Fredrikson S, Giovannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G. Eur J Neurol. 2018 May;25(5):739-746. |
Giovannoni G, Soelberg Sorensen P, Cook S, Rammohan K, Rieckmann P, Comi G, Dangond F, Adeniji AK, Vermersch P. Mult Scler. 2018 Oct;24(12):1594-1604. |
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Lancet Neurol. 2018 May;17(5):405-415. |
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. Mult Scler. 2018 Feb;24(2):96-120. |
Bone microarchitecture and bone mineral density in multiple sclerosis. Olsson A, Oturai AB, Søndergaard HB, Sellebjerg F, Oturai PS. Acta Neurol Scand. 2018 Mar;137(3):363-369. |
Clinical utility of anti-MOG antibody testing in a Danish cohort. Papp V, Langkilde AR, Blinkenberg M, Schreiber K, Jensen PEH, Sellebjerg F. Mult Scler Relat Disord. 2018 Nov;26:61-67. |
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T. Neurology. 2018 Dec 11;91(24):e2265-e2275. |
Pedersen EG, Hallas J, Pottegård A, Hald SM, Jensen PEH, Gaist D. Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):486-493. |
Smoking affects the interferon beta treatment response in multiple sclerosis. Petersen ER, Oturai AB, Koch-Henriksen N, Magyari M, Sørensen PS, Sellebjerg F, Søndergaard HB. Neurology. 2018 Feb 13;90(7):e593-e600. |
Inflammatory markers of CHMP2B-mediated frontotemporal dementia. Roos P, von Essen MR, Nielsen TT, Johannsen P, Stokholm J, Bie AS, Waldemar G, Simonsen AH, Heslegrave A, Zetterberg H; FReJA consortium, Sellebjerg F, Nielsen JE. J Neuroimmunol. 2018 Nov 15;324:136-142. |
Male factor infertility and risk of multiple sclerosis: A register-based cohort study. Glazer CH, Tøttenborg SS, Giwercman A, Bräuner EV, Eisenberg ML, Vassard D, Magyari M, Pinborg A, Schmidt L, Bonde JP. Mult Scler. 2018 Dec;24(14):1835-1842. |
Patient awareness about family planning represents a major knowledge gap in multiple sclerosis. Rasmussen PV, Magyari M, Moberg JY, Bøgelund M, Jensen UFA, Madsen KG. Mult Scler Relat Disord. 2018 Aug;24:129-134. |
Schreiber K, Kant M, Pfleger C, Jensen HB, Oesterberg O, Hald AR, Nielsen FK, Rubak S. Patient Prefer Adherence. 2018 Jun 29;12:1139-1150. |
De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group. Mult Scler. 2018 Feb;24(2):214-221. |
Svolgaard O, Andersen KW, Bauer C, Madsen KH, Blinkenberg M, Selleberg F, Siebner HR. PLoS One. 2018 Oct 24;13(10):e0201162. |
2017 |
Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Romme Nielsen B, Søndergaard HB, von Essen MR, Sellebjerg F. J Leukoc Biol. 2017 May;101(5):1211-1220. |
Bisgaard AK, Pihl-Jensen G, Frederiksen JL. Mult Scler Relat Disord. 2017 Nov;18:213-217. |
Blinkenberg M, Soelberg Sørensen P. CNS Drugs. 2017 May;31(5):357-371. |
Britze J, Pihl-Jensen G, Frederiksen JL. J Neurol. 2017 Sep;264(9):1837-1853. |
Buhelt S, Ratzer RL, Christensen JR, Börnsen L, Sellebjerg F, Søndergaard HB. Cytokine. 2017 May;93:15-25. |
Evolving concepts in the treatment of relapsing multiple sclerosis. Comi G, Radaelli M, Soelberg Sørensen P. Lancet. 2017 Apr 1;389(10076):1347-1356. |
de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, Frisoni GB, Sastre-Garriga J, Rovira A, Enzinger C, Filippi M, Frederiksen J, Ciccarelli O, Kappos L, Barkhof F, Vrenken H; MAGNIMS study group and for neuGRID. Neuroimage. 2017 Dec;163:106-114. |
Survey of diagnostic and treatment practices for multiple sclerosis in Europe. Fernández O, Delvecchio M, Edan G, Fredrikson S, Gionvannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G. Eur J Neurol. 2017 Mar;24(3):516-522. |
Sodium intake and multiple sclerosis activity and progression in BENEFIT. Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group. Ann Neurol. 2017 Jul;82(1):20-29. |
Vaccines and multiple sclerosis. Frederiksen JL, Topsøe Mailand M. Acta Neurol Scand. 2017 Nov;136 Suppl 201:49-51. |
Vaccines and multiple sclerosis: a systematic review. Mailand MT, Frederiksen JL. J Neurol. 2017 Jun;264(6):1035-1050. |
The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement. Hedström AK, Katsoulis M, Hössjer O, Bomfim IL, Oturai A, Sondergaard HB, Sellebjerg F, Ullum H, Thørner LW, Gustavsen MW, Harbo HF, Obradovic D, Gianfrancesco MA, Barcellos LF, Schaefer CA, Hillert J, Kockum I, Olsson T, Alfredsson L. Eur J Epidemiol. 2017 Oct;32(10):909-919. |
Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P. Mult Scler. 2017 Feb;23(2):234-241. |
Ingenhoven K, Kramer D, Jensen PE, Hermanrud C, Ryner M, Deisenhammer F, Pallardy M, Menge T, Hartung HP, Kieseier BC, Bertotti E, Creeke P, Fogdell-Hahn A, Warnke C. Front Neurol. 2017 Jul 6;8:305. |
Koch-Henriksen N, Laursen B, Stenager E, Magyari M. J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):626-631. |
Link J, Ramanujam R, Auer M, Ryner M, Hässler S, Bachelet D, Mbogning C, Warnke C, Buck D, Hyldgaard Jensen PE, Sievers C, Ingenhoven K, Fissolo N, Lindberg R, Grummel V, Donnellan N, Comabella M, Montalban X, Kieseier B, Soelberg Sørensen P, Hartung HP, Derfuss T, Lawton A, Sikkema D, Pallardy M, Hemmer B, Deisenhammer F, Broët P, Dönnes P, Davidson J, Fogdell-Hahn A; ABIRISK Consortium. PLoS One. 2017 Feb 7;12(2):e0170395. |
Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis. Lundell H, Svolgaard O, Dogonowski AM, Romme Christensen J, Selleberg F, Soelberg Sørensen P, Blinkenberg M, Siebner HR, Garde E. Acta Neurol Scand. 2017 Oct;136(4):330-337. |
Moberg JY, Larsen D, Brødsgaard A. J Clin Nurs. 2017 May;26(9-10):1363-1374. |
Employment, disability pension and income for children with parental multiple sclerosis. Moberg JY, Laursen B, Koch-Henriksen N, Thygesen LC, Brødsgaard A, Soelberg Sørensen P, Magyari M. Mult Scler. 2017 Jul;23(8):1148-1156. |
Nielsen NM, Harpsøe M, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Baker JL, Hjalgrim H, Frisch M, Bager P. Am J Epidemiol. 2017 Apr 15;185(8):712-719. |
Characterization of naïve, memory and effector T cells in progressive multiple sclerosis. Nielsen BR, Ratzer R, Börnsen L, von Essen MR, Christensen JR, Sellebjerg F. J Neuroimmunol. 2017 Sep 15;310:17-25. |
Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A. Neurology. 2017 Jan 3;88(1):44-51. |
Bone microarchitecture and bone mineral density in multiple sclerosis. Olsson A, Oturai AB, Søndergaard HB, Sellebjerg F, Oturai PS. Acta Neurol Scand. 2018 Mar;137(3):363-369. |
Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: A review. Pihl-Jensen G, Schmidt MF, Frederiksen JL. Clin Neurophysiol. 2017 Jul;128(7):1234-1245. |
Schreiber K, Magyari M, Sellebjerg F, Iversen P, Garde E, Madsen CG, Börnsen L, Romme Christensen J, Ratzer R, Siebner HR, Laursen B, Soelberg Sorensen P. Mult Scler. 2017 Apr;23(5):675-685. |
Defining active progressive multiple sclerosis. Sellebjerg F, Börnsen L, Ammitzbøll C, Nielsen JE, Vinther-Jensen T, Hjermind LE, von Essen M, Ratzer RL, Soelberg Sørensen P, Romme Christensen J. Mult Scler. 2017 Nov;23(13):1727-1735. |
Singh A, Subhi Y, Krogh Nielsen M, Falk MK, Matzen SMH, Sellebjerg F, Sørensen TL. Sci Rep. 2017 Apr 4;7(1):605. |
Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials. Sørensen PS, Comi G, Vollmer TL, Montalban X, Kappos L, Dadon Y, Gorfine T, Margalit M, Sasson N, Rubinchick S, Knappertz V. Int J MS Care. 2017 Jan-Feb;19(1):16-24. |
Søndergaard HB, Petersen ER, Magyari M, Sellebjerg F, Oturai AB. Mult Scler Relat Disord. 2017 Apr;13:25-27. |
Thormann A, Sørensen PS, Koch-Henriksen N, Thygesen LC, Laursen B, Magyari M. Eur J Neurol. 2017 Jun;24(6):825-834. c |
Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Thormann A, Sørensen PS, Koch-Henriksen N, Laursen B, Magyari M. Neurology. 2017 Oct 17;89(16):1668-1675. |
Early safety and efficacy of fingolimod treatment in Denmark. Voldsgaard A, Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen PS, Oturai AB. Acta Neurol Scand. 2017 Jan;135(1):129-133. |
2016 |
Degn M, Modvig S, Dyring-Andersen B, Bonefeld CM, Frederiksen JL, Geisler C, von Essen MR. Mult Scler. 2016 Jul;22(8):1013-20. |
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis. Ratzer R, Iversen P, Börnsen L, Dyrby TB, Romme Christensen J, Ammitzbøll C, Madsen CG, Garde E, Lyksborg M, Andersen B, Hyldstrup L, Sørensen PS, Siebner HR, Sellebjerg F. Mult Scler. 2016 Jun;22(7):926-34. |
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis. Modvig S, Degn M, Sander B, Horwitz H, Wanscher B, Sellebjerg F, Frederiksen JL. Mult Scler. 2016 Apr;22(5):590-8. |
Dogonowski AM, Blinkenberg M, Paulson OB, Sellebjerg F, Sørensen PS, Siebner HR, Madsen KH. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):912-4. |
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease. Vinther-Jensen T, Börnsen L, Budtz-Jørgensen E, Ammitzbøll C, Larsen IU, Hjermind LE, Sellebjerg F, Nielsen JE. Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e287. |
Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort. Thormann A, Koch-Henriksen N, Laursen B, Sørensen PS, Magyari M. Mult Scler Relat Disord. 2016 Nov;10:181-186. |
Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS. J Neurol. 2016 Dec;263(12):2484-2493. |
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk. International Multiple Sclerosis Genetics Consortium. Electronic address: cotsapas@broadinstitute.org; International Multiple Sclerosis Genetics Consortium. Neuron. 2016 Oct 19;92(2):333-335. |
Ozanimod: a better or just another S1P receptor modulator? Sørensen PS. Lancet Neurol. 2016 Apr;15(4):345-7. |
Sorensen PS, Blinkenberg M. Ther Adv Neurol Disord. 2016 Jan;9(1):44-52. |
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO. Soelberg Sorensen P. Mult Scler. 2016 Sep;22(10):1260-3. |
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis. Soelberg Sorensen P, Sellebjerg F. Mult Scler. 2016 Aug;22(9):1112-3. |
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study. Sørensen PS, Sellebjerg F, Lycke J, Färkkilä M, Créange A, Lund CG, Schluep M, Frederiksen JL, Stenager E, Pfleger C, Garde E, Kinnunen E, Marhardt K; RECYCLINE Study Investigators. Eur J Neurol. 2016 May;23(5):861-70. |
Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs? Sørensen PS. Nat Rev Neurol. 2016 Jan;12(1):5-6. |
Safety concerns and risk management of multiple sclerosis therapies. Soelberg Sorensen P. Acta Neurol Scand. 2017 Sep;136(3):168-186. |
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis. Sellebjerg F, Cadavid D, Steiner D, Villar LM, Reynolds R, Mikol D. Ther Adv Neurol Disord. 2016 Jan;9(1):31-43. |
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis. Ratzer R, Iversen P, Börnsen L, Dyrby TB, Romme Christensen J, Ammitzbøll C, Madsen CG, Garde E, Lyksborg M, Andersen B, Hyldstrup L, Sørensen PS, Siebner HR, Sellebjerg F. Mult Scler. 2016 Jun;22(7):926-34. |
Petersen ER, Søndergaard HB, Oturai AB, Jensen P, Sorensen PS, Sellebjerg F, Börnsen L. Mult Scler Relat Disord. 2016 Nov;10:66-72. |
Oturai DB, Søndergaard HB, Börnsen L, Sellebjerg F, Christensen JR. Scand J Immunol. 2016 Jan;83(1):72-80. |
Otero-Romero S, Sastre-Garriga J, Comi G, Hartung HP, Soelberg Sørensen P, Thompson AJ, Vermersch P, Gold R, Montalban X. Mult Scler. 2016 Oct;22(11):1386-1396. |
The association between multiple sclerosis and uveitis. Olsen TG, Frederiksen J. Surv Ophthalmol. 2017 Jan-Feb;62(1):89-95. |
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study. O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas. Neurology. 2016 Mar 8;86(10):920-30. |
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination. Al Nimer F, Elliott C, Bergman J, Khademi M, Dring AM, Aeinehband S, Bergenheim T, Romme Christensen J, Sellebjerg F, Svenningsson A, Linington C, Olsson T, Piehl F. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e191. |
Nielsen NM, Harpsøe MC, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Frisch M, Bager P. Mult Scler. 2016 Oct;22(11):1444-1451. |
Nielsen CH, Börnsen L, Sellebjerg F, Brimnes MK. PLoS One. 2016 Jan 12;11(1):e0146971. |
Møllgaard M, Degn M, Sellebjerg F, Frederiksen JL, Modvig S. Eur J Neurol. 2016 May;23(5):898-905. |
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis. Modvig S, Degn M, Sander B, Horwitz H, Wanscher B, Sellebjerg F, Frederiksen JL. Mult Scler. 2016 Apr;22(5):590-8. |
Moberg JY, Magyari M, Koch-Henriksen N, Thygesen LC, Laursen B, Soelberg Sørensen P. J Neurol. 2016 Nov;263(11):2229-2237. |
Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P; IMSVISUAL consortium. Lancet Neurol. 2016 May;15(6):574-84. |
The Danish Multiple Sclerosis Treatment Register. Magyari M, Koch-Henriksen N, Sørensen PS. Clin Epidemiol. 2016 Oct 25;8:549-552. |
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine. Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P. Mult Scler. 2016 Jun;22(7):944-54. |
Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators. Lancet. 2016 Mar 12;387(10023):1075-1084. |
Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB. Mult Scler Relat Disord. 2016 Nov;10:169-173. |
Association between age at onset of multiple sclerosis and vitamin D level-related factors. Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB. Neurology. 2016 Jan 5;86(1):88-93. |
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS. Lam MA, Maghzal GJ, Khademi M, Piehl F, Ratzer R, Romme Christensen J, Sellebjerg FT, Olsson T, Stocker R. Neurol Neuroimmunol Neuroinflamm. 2016 Jun 30;3(4):e256. |
Hermanrud C, Ryner M, Luft T, Jensen PE, Ingenhoven K, Rat D, Deisenhammer F, Sørensen PS, Pallardy M, Sikkema D, Bertotti E, Kramer D, Creeke P, Fogdell-Hahn A; ABIRISK Consortium. J Immunol Methods. 2016 Mar;430:1-9. |
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Hegen H, Adrianto I, Lessard CJ, Millonig A, Bertolotto A, Comabella M, Giovannoni G, Guger M, Hoelzl M, Khalil M, Fazekas F, Killestein J, Lindberg RL, Malucchi S, Mehling M, Montalban X, Rudzki D, Schautzer F, Sellebjerg F, Sorensen PS, Deisenhammer F, Steinman L, Axtell RC. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. |
Gustavsen S, Søndergaard HB, Oturai DB, Laursen B, Laursen JH, Magyari M, Ullum H, Larsen MH, Sellebjerg F, Oturai AB. Mult Scler Relat Disord. 2016 Sep;9:104-9. |
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients. Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Neurology. 2016 Nov 8;87(19):1985-1992. |
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL, D'Alfonso S, Leone MA, Martinelli Boneschi F, Sorosina M, van der Mei I, Taylor BV, Zhou Y, Schaefer C, Barcellos LF. Neurol Genet. 2016 Aug 4;2(4):e87. |
Human pegivirus detected in a patient with severe encephalitis using a metagenomic pan-virus array. Fridholm H, Østergaard Sørensen L, Rosenstierne MW, Nielsen H, Sellebjerg F, Bengård Andersen Å, Fomsgaard A. J Clin Virol. 2016 Apr;77:5-8. |
Dogonowski AM, Blinkenberg M, Paulson OB, Sellebjerg F, Sørensen PS, Siebner HR, Madsen KH. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):912-4. |
Dalbjerg SM, Tsakiri A, Frederiksen JL. Mult Scler Relat Disord. 2016 Jul;8:93-5. |
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P; IMSVISUAL consortium. Neurology. 2016 Jun 14;86(24):2303-9. |
Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Bredholt M, Frederiksen JL. ASN Neuro. 2016 Jun 9;8(3):1759091416651511. |
Bachelet D, Hässler S, Mbogning C, Link J, Ryner M, Ramanujam R, Auer M, Hyldgaard Jensen PE, Koch-Henriksen N, Warnke C, Ingenhoven K, Buck D, Grummel V, Lawton A, Donnellan N, Hincelin-Mery A, Sikkema D, Pallardy M, Kieseier B, Hemmer B, Hartung HP, Soelberg Sorensen P, Deisenhammer F, Dönnes P, Davidson J, Fogdell-Hahn A, Broët P; ABIRISK Consortium. PLoS One. 2016 Nov 2;11(11):e0162752. |
2015 |
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis? Sellebjerg F, Oturai AB. Nat Rev Neurol. 2015 Jul;11(7):371-2. |
Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF. Ann Neurol. 2015 Nov;78(5):710-21. |
Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F; ABIRISK Consortium. Clin Exp Immunol. 2015 Sep;181(3):385-400. |
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Taylor JC, Martin HC, Lise S, Broxholme J, Cazier JB, Rimmer A, Kanapin A, Lunter G, Fiddy S, Allan C, Aricescu AR, Attar M, Babbs C, Becq J, Beeson D, Bento C, Bignell P, Blair E, Buckle VJ, Bull K, Cais O, Cario H, Chapel H, Copley RR, Cornall R, Craft J, Dahan K, Davenport EE, Dendrou C, Devuyst O, Fenwick AL, Flint J, Fugger L, Gilbert RD, Goriely A, Green A, Greger IH, Grocock R, Gruszczyk AV, Hastings R, Hatton E, Higgs D, Hill A, Holmes C, Howard M, Hughes L, Humburg P, Johnson D, Karpe F, Kingsbury Z, Kini U, Knight JC, Krohn J, Lamble S, Langman C, Lonie L, Luck J, McCarthy D, McGowan SJ, McMullin MF, Miller KA, Murray L, Németh AH, Nesbit MA, Nutt D, Ormondroyd E, Oturai AB, Pagnamenta A, Patel SY, Percy M, Petousi N, Piazza P, Piret SE, Polanco-Echeverry G, Popitsch N, Powrie F, Pugh C, Quek L, Robbins PA, Robson K, Russo A, Sahgal N, van Schouwenburg PA, Schuh A, Silverman E, Simmons A, Sørensen PS, Sweeney E, Taylor J, Thakker RV, Tomlinson I, Trebes A, Twigg SR, Uhlig HH, Vyas P, Vyse T, Wall SA, Watkins H, Whyte MP, Witty L, Wright B, Yau C, Buck D, Humphray S, Ratcliffe PJ, Bell JI, Wilkie AO, Bentley D, Donnelly P, McVean G. Nat Genet. 2015 Jul;47(7):717-726. |
Olsson A, Oturai DB, Sørensen PS, Oturai PS, Oturai AB. Mult Scler. 2015 Oct;21(12):1557-65. |
Börnsen L, Romme Christensen J, Ratzer R, Hedegaard C, Søndergaard HB, Krakauer M, Hesse D, Nielsen CH, Sorensen PS, Sellebjerg F. PLoS One. 2015 Mar 4;10(3):e0118830. |
Class II HLA interactions modulate genetic risk for multiple sclerosis. Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A, Gourraud PA, Graetz C, Hemmer B, Hillert J; International IBD Genetics Consortium (IIBDGC), Kockum I, Leslie S, Lill CM, Martinelli-Boneschi F, Oksenberg JR, Olsson T, Oturai A, Saarela J, Søndergaard HB, Spurkland A, Taylor B, Winkelmann J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CCA, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Hauser SL, De Jager PL, Compston A, McCauley JL, Sawcer S, McVean G. Nat Genet. 2015 Oct;47(10):1107-1113. |
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA; International Multiple Sclerosis Genetics Consortium, Sawcer SJ, Andreassen BK, Dubois B, Harbo HF. Brain. 2015 Mar;138(Pt 3):632-43. |
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Marrie RA, Reider N, Cohen J, Stuve O, Sorensen PS, Cutter G, Reingold SC, Trojano M. Mult Scler. 2015 Mar;21(3):282-93. |
Modvig S, Degn M, Roed H, Sørensen TL, Larsson HB, Langkilde AR, Frederiksen JL, Sellebjerg F. Mult Scler. 2015 Dec;21(14):1761-70. |
Registers of multiple sclerosis in Denmark. Koch-Henriksen N, Magyari M, Laursen B. Acta Neurol Scand. 2015;132(199):4-10. |
Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis. Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A. Mult Scler. 2015 Oct;21(11):1414-22. |
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J. Eur J Hum Genet. 2015 May;23(5):688-92. |
Penner IK, Sivertsdotter EC, Celius EG, Fuchs S, Schreiber K, Berkö S, Svenningsson A; TYNERGY trial investigators. Front Neurol. 2015 Feb 23;6:18. |
Marrie RA, Reider N, Stuve O, Trojano M, Sorensen PS, Cutter GR, Reingold SC, Cohen J. Mult Scler. 2015 Mar;21(3):332-41. |
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, Cutter G, Reider N. Mult Scler. 2015 Mar;21(3):305-17. |
The use of valproic acid and multiple sclerosis. Nielsen NM, Svanström H, Stenager E, Magyari M, Koch-Henriksen N, Pasternak B, Hviid A. Pharmacoepidemiol Drug Saf. 2015 Mar;24(3):262-8. |
2014 |
Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R, Malucchi S, Mehling M, Montalban X, Polman CH, Rudzki D, Schautzer F, Sellebjerg F, Sørensen PS, Deisenhammer F. Mult Scler. 2014 Apr;20(5):577-87. |
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis. Møller M, Søndergaard HB, Koch-Henriksen N, Sorensen PS, Sellebjerg F, Oturai AB. Acta Neurol Scand. 2014 Jan;129(1):27-31. |
Liu Y, Carlsson R, Comabella M, Wang J, Kosicki M, Carrion B, Hasan M, Wu X, Montalban X, Dziegiel MH, Sellebjerg F, Sørensen PS, Helin K, Issazadeh-Navikas S. Nat Med. 2014 Mar;20(3):272-82. |
Lyksborg M, Siebner HR, Sørensen PS, Blinkenberg M, Parker GJ, Dogonowski AM, Garde E, Larsen R, Dyrby TB. PLoS One. 2014 Apr 18;9(4):e95540. |
Myasthenia and risk of cancer: a population-based case-control study. Pedersen EG, Pottegård A, Hallas J, Friis S, Hansen K, Jensen PE, Gaist D. Eur J Neurol. 2014 May;21(5):773-8. |
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine. Pedersen EG, Pottegård A, Hallas J, Friis S, Hansen K, Jensen PE, Gaist D. Eur J Neurol. 2014 Mar;21(3):454-8. |
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis. Ratzer R, Romme Christensen J, Romme Nielsen B, Sørensen PS, Börnsen L, Sellebjerg F. J Neuroimmunol. 2014 Nov 15;276(1-2):195-201. |
Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial. Romme Christensen J, Ratzer R, Börnsen L, Lyksborg M, Garde E, Dyrby TB, Siebner HR, Sorensen PS, Sellebjerg F. Neurology. 2014 Apr 29;82(17):1499-507. |
Prediction of response to interferon therapy in multiple sclerosis. Sellebjerg F, Søndergaard HB, Koch-Henriksen N, Sørensen PS, Oturai AB. Acta Neurol Scand. 2014 Oct;130(4):268-75. |
New management algorithms in multiple sclerosis. Sorensen PS. Curr Opin Neurol. 2014 Jun;27(3):246-59. |
Sorensen PS, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F. J Neurol. 2014 Jun;261(6):1170-7. |
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J. Eur J Hum Genet. 2015 May;23(5):688-92. |
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis. Wu X, Hanson LG, Skimminge A, Sorensen PS, Paulson OB, Mathiesen HK, Blinkenberg M. Neurol Res. 2014 Aug;36(8):701-8. |
Onset symptoms in paediatric multiple sclerosis. Boesen MS, Sellebjerg F, Blinkenberg M. Dan Med J. 2014 Apr;61(4):A4800. |
CLIPPERS among patients diagnosed with non-specific CNS neuroinflammatory diseases. Kerrn-Jespersen BM, Lindelof M, Illes Z, Blaabjerg M, Lund EL, Klausen C, Christiansen I, Sellebjerg F, Kondziella D. J Neurol Sci. 2014 Aug 15;343(1-2):224-7. |
Clinical relevance of brain volume measures in multiple sclerosis. De Stefano N, Airas L, Grigoriadis N, Mattle HP, O'Riordan J, Oreja-Guevara C, Sellebjerg F, Stankoff B, Walczak A, Wiendl H, Kieseier BC. CNS Drugs. 2014 Feb;28(2):147-56. |
Enevold C, Kjær L, Nielsen CH, Voss A, Jacobsen RS, Hermansen ML, Redder L, Oturai AB, Jensen PE, Bendtzen K, Jacobsen S. Rheumatol Int. 2014 Oct;34(10):1401-8. |
Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF. J Neuroimmunol. 2014 Sep 15;274(1-2):174-9. |
Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R, Malucchi S, Mehling M, Montalban X, Polman CH, Rudzki D, Schautzer F, Sellebjerg F, Sørensen PS, Deisenhammer F. Mult Scler. 2014 Apr;20(5):577-87. |
Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis. Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A. Mult Scler. 2015 Oct;21(11):1414-22. |
2013 |
Magyari M, Bach Søndergaard H, Sellebjerg F, Soelberg Sørensen P. Mult Scler Relat Disord. 2013 Apr;2(2):141-6. |
Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009. Pedersen EG, Hallas J, Hansen K, Jensen PE, Gaist D. Eur J Neurol. 2013 Feb;20(2):309-14. |
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis. Romme Christensen J, Börnsen L, Khademi M, Olsson T, Jensen PE, Sørensen PS, Sellebjerg F. Mult Scler. 2013 Jun;19(7):877-84. |
Sellebjerg F, Hesse D, Limborg S, Lund H, Søndergaard HB, Krakauer M, Sørensen PS. Mult Scler. 2013 Feb;19(2):179-87. |
Blinkenberg M, Sellebjerg F, Leffers AM, Madsen CG, Sørensen PS. Mult Scler. 2013 Aug;19(9):1226-9. |
International Multiple Sclerosis Genetics Consortium. Am J Hum Genet. 2013 Jun 6;92(6):854-65. |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, McCauley JL. Nat Genet. 2013 Nov;45(11):1353-60. |
Lund H, Krakauer M, Skimminge A, Sellebjerg F, Garde E, Siebner HR, Paulson OB, Hesse D, Hanson LG. PLoS One. 2013;8(2):e56375. |
Reproduction and the risk of multiple sclerosis. Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS. Mult Scler. 2013 Oct;19(12):1604-9. |
Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH; International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF. PLoS One. 2013;8(3):e58352. |
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Olsson T, Achiron A, Alfredsson L, Berger T, Brassat D, Chan A, Comi G, Eraksoy M, Hegen H, Hillert J, Jensen PE, Moiola L, Myhr KM, Oturai A, Schippling S, Siva A, Sorensen PS, Trampe AK, Weber T, Potts J, Plavina T, Paes D, Subramanyam M, Wiendl H, Dib H, Uren D, Hemmer B, Buck D. Mult Scler. 2013 Oct;19(11):1533-8. |
Pedersen EG, Pottegård A, Hallas J, Friis S, Hansen K, Jensen PE, Gaist D. Eur J Neurol. 2013 Jun;20(6):942-8. |
Romme Christensen J, Börnsen L, Ratzer R, Piehl F, Khademi M, Olsson T, Sørensen PS, Sellebjerg F. PLoS One. 2013;8(3):e57820. |
Svenningsson A, Falk E, Celius EG, Fuchs S, Schreiber K, Berkö S, Sun J, Penner IK; Tynergy Trial Investigators. PLoS One. 2013;8(3):e58643. |
Differential microRNA expression in blood in multiple sclerosis. Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F. Mult Scler. 2013 Dec;19(14):1849-57. |
Theibich A, Dreyer L, Magyari M, Locht H. Clin Rheumatol. 2014 May;33(5):719-23. |
Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis. Mathiesen HK, Sorensen PS. Expert Rev Neurother. 2013 Dec;13(12):1309-17. |
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis. Dogonowski AM, Siebner HR, Soelberg Sørensen P, Paulson OB, Dyrby TB, Blinkenberg M, Madsen KH. Acta Neurol Scand. 2013 Nov;128(5):328-35. |
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study. Comi G, Cook SD, Giovannoni G, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Hamlett AC, Viglietta V, Greenberg SJ. J Neurol. 2013 Apr;260(4):1136-46. |
2012 |
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis. Sellebjerg F, Hedegaard CJ, Krakauer M, Hesse D, Lund H, Nielsen CH, Søndergaard HB, Sørensen PS. Mult Scler. 2012 Mar;18(3):305-13. |
Blinkenberg M, Mathiesen HK, Tscherning T, Jønsson A, Svarer C, Holm S, Sellebjerg F, Paulson OB, Hanson LG, Sorensen PS. Neurol Res. 2012 Jan;34(1):52-8. |
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis. Blinkenberg M, Akeson P, Sillesen H, Lövgaard S, Sellebjerg F, Paulson OB, Siebner HR, Sørensen PS. Acta Neurol Scand. 2012 Dec;126(6):421-7. |
Brambilla P, Esposito F, Lindstrom E, Sorosina M, Giacalone G, Clarelli F, Rodegher M, Colombo B, Moiola L, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, Celius EG, Galimberti D, Sørensen PS, Martinelli V, Oturai AB, Harbo HF, Hillert J, Comi G, Martinelli-Boneschi F. Neurosci Lett. 2012 Nov 21;530(2):155-60. |
Braendstrup P, Langkilde AR, Schreiber K, Ravnborg M, Sellebjerg F, Vindeløv L. Case Rep Neurol. 2012 May;4(2):101-6. |
Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis. Börnsen L, Christensen JR, Ratzer R, Oturai AB, Sørensen PS, Søndergaard HB, Sellebjerg F. PLoS One. 2012;7(11):e47578. |
Dogonowski AM, Siebner HR, Sørensen PS, Wu X, Biswal B, Paulson OB, Dyrby TB, Skimminge A, Blinkenberg M, Madsen KH. Mult Scler. 2013 Apr;19(5):559-66. |
Prediction of antibody persistency from antibody titres to natalizumab. Jensen PE, Koch-Henriksen N, Sellebjerg F, Sørensen PS. Mult Scler. 2012 Oct;18(10):1493-9. |
Jensen PE, Sellebjerg F, Søndergaard HB, Sørensen PS. Eur J Neurol. 2012 Oct;19(10):1311-7. |
A genome-wide association study in progressive multiple sclerosis. Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, Stankovich J, Rodegher M, Capra R, Ghezzi A, Coniglio G, Colombo B, Sorosina M, Martinelli V, Booth D, Oturai AB, Stewart G, Harbo HF, Kilpatrick TJ, Hillert J, Rubio JP, Abderrahim H, Wojcik J, Comi G. Mult Scler. 2012 Oct;18(10):1384-94. |
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. Romme Christensen J, Börnsen L, Hesse D, Krakauer M, Sørensen PS, Søndergaard HB, Sellebjerg F. J Neuroinflammation. 2012 Sep 14;9:215. |
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis. Sellebjerg F, Krakauer M, Limborg S, Hesse D, Lund H, Langkilde A, Søndergaard HB, Sørensen PS. PLoS One. 2012;7(6):e35927. |
Sellebjerg F, Krakauer M, Khademi M, Olsson T, Sørensen PS. Clin Exp Immunol. 2012 Nov;170(2):149-55. |
Ali S, Paracha N, Cook S, Giovannoni G, Comi G, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Greenberg S, Scott DA, Joyeux A; CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) Study Group. Clin Drug Investig. 2012 Jan 1;32(1):15-27. |
Effects of neutralizing antibodies to interferon beta in multiple sclerosis: a logical paradox. Sørensen PS. Mult Scler. 2012 Feb;18(2):131-2. |
Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Tümer Z, Bertelsen B, Gredal O, Magyari M, Nielsen KC, Lucamp, Grønskov K, Brøndum-Nielsen K. Neurobiol Aging. 2012 Jan;33(1):208.e1-5. |
2011 |
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Compston A. Nature. 2011 Aug 10;476(7359):214-9. |
Nexø BA, Christensen T, Frederiksen J, Møller-Larsen A, Oturai AB, Villesen P, Hansen B, Nissen KK, Laska MJ, Petersen TS, Bonnesen S, Hedemand A, Wu T, Wang X, Zhang X, Brudek T, Maric R, Søndergaard HB, Sellebjerg F, Brusgaard K, Kjeldbjerg AL, Rasmussen HB, Nielsen AL, Nyegaard M, Petersen T, Børglum AD, Pedersen FS. PLoS One. 2011 Feb 2;6(2):e16652. |
Sørensen PS, Jensen PE, Haghikia A, Lundkvist M, Vedeler C, Sellebjerg F, Koch-Henriksen N, Fogdell-Hahn A, Myhr KM, Hillert J, Gold R. Mult Scler. 2011 Sep;17(9):1074-8. |
Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab. Sørensen PS, Koch-Henriksen N, Jensen PE. Neurology. 2011 Feb 22;76(8):759-60. |
Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB; SIMCOMBIN study investigators. Lancet Neurol. 2011 Aug;10(8):691-701. |
Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB. Eur J Hum Genet. 2011 Oct;19(10):1100-3. |
Identifying patients with myasthenia for epidemiological research by linkage of automated registers. Pedersen EG, Hallas J, Hansen K, Jensen PE, Gaist D. Neuroepidemiology. 2011;37(2):120-8. |
Hedegaard CJ, Sellebjerg F, Krakauer M, Hesse D, Bendtzen K, Nielsen CH. Mult Scler. 2011 May;17(5):567-77. |
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis? Hesse D, Krakauer M, Lund H, Søndergaard HB, Limborg SJ, Sørensen PS, Sellebjerg F. Eur J Neurol. 2011 Feb;18(2):266-72. |
Börnsen L, Khademi M, Olsson T, Sørensen PS, Sellebjerg F. Mult Scler. 2011 Jan;17(1):32-42. |
Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis. Hedegaard CJ, Enevold C, Sellebjerg F, Bendtzen K, Nielsen CH. PLoS One. 2011;6(5):e20253. |
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis? Hesse D, Krakauer M, Lund H, Søndergaard HB, Limborg SJ, Sørensen PS, Sellebjerg F. Eur J Neurol. 2011 Feb;18(2):266-72. |
Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T. Mult Scler. 2011 Mar;17(3):335-43. |
International Multiple Sclerosis Genetics Consortium. PLoS One. 2011 Apr 28;6(4):e18813. |
2010 |
Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sørensen PS, Lorentzen AR, Celius EG, Leppä V, Koivisto K, Tienari PJ, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, Olsson T. Genes Immun. 2010 Mar;11(2):142-54 |
Demyelination versus remyelination in progressive multiple sclerosis. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H. Brain. 2010 Oct;133(10):2983-98. |
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF. Eur J Hum Genet. 2010 Apr;18(4):502-4 |
The changing demographic pattern of multiple sclerosis epidemiology. Koch-Henriksen N, Sørensen PS. Lancet Neurol. 2010 May;9(5):520-32 |
Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA, Daly MJ, Palotie A, Saarela J, Peltonen L. Am J Hum Genet. 2010 Feb 12;86(2):285-91 |
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. International Multiple Sclerosis Genetics Conssortium (IMSGC). Genes Immun. 2010 Jul;11(5):397-405 |
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response. Hesse D, Krakauer M, Lund H, Søndergaard HB, Langkilde A, Ryder LP, Sorensen PS, Sellebjerg F. Neurology. 2010 May 4;74(18):1455-62 |
Enevold C, Oturai AB, Sørensen PS, Ryder LP, Koch-Henriksen N, Bendtzen K. Mult Scler. 2010 Aug;16(8):942-9. |
RGMA and IL21R show association with experimental inflammation and multiple sclerosis. Nohra R, Beyeen AD, Guo JP, Khademi M, Sundqvist E, Hedreul MT, Sellebjerg F, Smestad C, Oturai AB, Harbo HF, Wallström E, Hillert J, Alfredsson L, Kockum I, Jagodic M, Lorentzen J, Olsson T. Genes Immun. 2010 Jun;11(4):279-93. |